Filana Therapeutics, Inc. (FLNA) stock
FLNANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$0.64+0.08 (+14.52%)
Close on Nov 20, 2026Market cap $30.98MP/E –Yield –
Filana Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Filana Therapeutics's total assets was $103.90M at Jun 30, 2026. For fiscal 2025 it was $118.36M, down 24.9% from the year before. Over ten years it grew 14.0% a year on average. The highest annual figure on record is $266.78M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $118.36M | -24.9% |
| FY2024 | Dec 31, 2024 | $157.53M | +3.9% |
| FY2023 | Dec 31, 2023 | $151.66M | -35.4% |
| FY2022 | Dec 31, 2022 | $234.83M | -12.0% |
| FY2021 | Dec 31, 2021 | $266.78M | +182.9% |
| FY2020 | Dec 31, 2020 | $94.30M | +301.5% |
| FY2019 | Dec 31, 2019 | $23.49M | +16.6% |
| FY2018 | Dec 31, 2018 | $20.14M | +85.9% |
| FY2017 | Dec 31, 2017 | $10.83M | -43.9% |
| FY2016 | Dec 31, 2016 | $19.30M | -39.5% |
| FY2015 | Dec 31, 2015 | $31.92M | -22.0% |
| FY2014 | Dec 31, 2014 | $40.91M | -18.4% |
| FY2013 | Dec 31, 2013 | $50.10M | -11.9% |
| FY2012 | Dec 31, 2012 | $56.86M | -42.5% |
| FY2011 | Dec 31, 2011 | $98.96M | -0.2% |
| FY2010 | Dec 31, 2010 | $99.20M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $103.90M | -23.3% |
| Q1 FY2026 | Mar 31, 2026 | $108.37M | -23.1% |
| Q4 FY2025 | Dec 31, 2025 | $118.36M | -24.9% |
| Q3 FY2025 | Sep 30, 2025 | $129.73M | -42.0% |
| Q2 FY2025 | Jun 30, 2025 | $135.38M | -44.4% |
| Q1 FY2025 | Mar 31, 2025 | $140.93M | -9.5% |
| Q4 FY2024 | Dec 31, 2024 | $157.53M | +3.9% |
| Q3 FY2024 | Sep 30, 2024 | $223.75M | +29.7% |
| Q2 FY2024 | Jun 30, 2024 | $243.57M | +23.5% |
| Q1 FY2024 | Mar 31, 2024 | $155.72M | -28.6% |
| Q4 FY2023 | Dec 31, 2023 | $151.66M | -35.4% |
| Q3 FY2023 | Sep 30, 2023 | $172.53M | -16.8% |
| Q2 FY2023 | Jun 30, 2023 | $197.25M | -13.3% |
| Q1 FY2023 | Mar 31, 2023 | $218.11M | -10.7% |
| Q4 FY2022 | Dec 31, 2022 | $234.83M | -12.0% |
| Q3 FY2022 | Sep 30, 2022 | $207.29M | -24.4% |
| Q2 FY2022 | Jun 30, 2022 | $227.38M | -19.2% |
| Q1 FY2022 | Mar 31, 2022 | $244.19M | -14.0% |
| Q4 FY2021 | Dec 31, 2021 | $266.78M | +182.9% |
| Q3 FY2021 | Sep 30, 2021 | $274.25M | +979.8% |
| Q2 FY2021 | Jun 30, 2021 | $281.31M | +1003.2% |
| Q1 FY2021 | Mar 31, 2021 | $284.05M | +993.5% |
| Q4 FY2020 | Dec 31, 2020 | $94.30M | +301.5% |
| Q3 FY2020 | Sep 30, 2020 | $25.40M | +38.2% |
| Q2 FY2020 | Jun 30, 2020 | $25.50M | +35.6% |
| Q1 FY2020 | Mar 31, 2020 | $25.98M | +33.1% |
| Q4 FY2019 | Dec 31, 2019 | $23.49M | +16.6% |
| Q3 FY2019 | Sep 30, 2019 | $18.38M | -11.8% |
| Q2 FY2019 | Jun 30, 2019 | $18.81M | +91.2% |
| Q1 FY2019 | Mar 31, 2019 | $19.52M | +76.6% |
| Q4 FY2018 | Dec 31, 2018 | $20.14M | +85.9% |
| Q3 FY2018 | Sep 30, 2018 | $20.84M | +68.3% |
| Q2 FY2018 | Jun 30, 2018 | $9.83M | -31.1% |
| Q1 FY2018 | Mar 31, 2018 | $11.06M | -37.2% |
| Q4 FY2017 | Dec 31, 2017 | $10.83M | -43.9% |
| Q3 FY2017 | Sep 30, 2017 | $12.38M | -44.9% |
| Q2 FY2017 | Jun 30, 2017 | $14.27M | – |
| Q1 FY2017 | Mar 31, 2017 | $17.60M | – |
| Q4 FY2016 | Dec 31, 2016 | $19.30M | – |
| Q3 FY2016 | Sep 30, 2016 | $22.48M | – |
See a number that looks wrong?